Clinical and Applied Thrombosis/Hemostasis-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1189677, encodeId=13e611896e7f8, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：出凝血疾病 经验分享：大年初一，文章接收，很高兴第一次跟大家分享自己这次的投稿经历 投稿时间：2021-11-7 第一次寻找审稿人：2021-11-15【未找到合适的审稿人】 第二次寻找审稿人：2021-12-20【这一次匹配到了合适的审稿人】 第一次有审稿意见（小修）：2022-1-25——修回时间2022-1-30 第二次有审稿意见（接收）：2022-2-1 总体感觉审稿速度还是不错的，文章之前投过其他杂志，虽然未接收，但是根据审稿意见进行了一些修改，对文章结构有明显改善，所以这次接收速度很快，希望对大家有所帮助！ 2022年希望各位都能多发文章！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1f381668772, createdName=Su2016, createdTime=Wed Feb 02 11:28:12 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2248555, encodeId=3904224855562, content=投稿命中率:50.0 偏重的研究方向：出凝血疾病 经验分享：2024.12.18提交 2024.12.19 Reviewers are being invited and responses are being received 2024.12.28 Reviewers have been assigned and are completing reviews 一审结果未回持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5665325686, createdName=TJJQQ, createdTime=Fri Jan 17 23:18:06 CST 2025, time=2025-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101680, encodeId=809a210168062, content=偏重的研究方向：出凝血疾病 经验分享：2022.11.18提交 2022.11.19 Reviewers are being invited and responses are being received …持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e8349335, createdName=ms5000000019231764, createdTime=Sun Nov 20 23:13:04 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203613, encodeId=147922036133f, content=请问大家返修后Reviewers have been assigned and are completing reviews这个状态持续了多久呀等的实在太焦虑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b249042506, createdName=ms6000001836781261, createdTime=Thu May 09 10:09:09 CST 2024, time=2024-05-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109182, encodeId=ece72109182f2, content=2023.1.2接收，感觉审稿速度还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/7768d054ebc26df3dfa69122edc74935.jpg, createdBy=34ce1684797, createdName=1de4308em68(暂无匿称), createdTime=Fri Jan 06 22:14:24 CST 2023, time=2023-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1062859, encodeId=1e2f106285954, content=分享一下，proof之后2周就可以online了，需要自己检索 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=晔儿SK, createdTime=Fri Oct 22 09:36:18 CST 2021, time=2021-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211718, encodeId=4e692211e1825, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肺栓塞 经验分享：肺栓塞方向的文章 1.25投稿 3.25大修编辑的意见很专业细致，第一个编辑侧重点是需要说明文章的临床价值和背后的机制解释。有点忙隔了几个月才好好修，编辑没有催，好像是6个月还不返修需要向编辑说明。 6.6 返修 6.20 接受 人生第一篇独立的SCI！完美！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72015631190, createdName=ms4000001583451710, createdTime=Wed Jun 26 13:25:24 CST 2024, time=2024-06-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2178714, encodeId=706a21e8714ca, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这期刊编辑沟通顺畅，问题指出明确，真的很省心。投稿后编辑反馈及时，明白表达观点，省了好多麻烦，可以持续关注，希望明年影响因子能再提高一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfc06407071, createdName=ms5463223, createdTime=Tue Jan 02 09:34:01 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177818, encodeId=8f1721e7818d0, content=这期刊审稿效率还不错，一审一个月回复！而且编辑意见还很中肯，认真修改后2个月接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Thu Dec 28 16:36:16 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2118241, encodeId=12cb21182415b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：血栓 经验分享：交版面费时没有visa,mstercard,银联可以交么？<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>switch是什么卡, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99b78341791, createdName=ms3000001727854429, createdTime=Wed Mar 08 09:13:24 CST 2023, time=2023-03-08, status=1, ipAttribution=四川省)]

2022-02-02 Su2016

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：出凝血疾病
经验分享：大年初一，文章接收，很高兴第一次跟大家分享自己这次的投稿经历
投稿时间：2021-11-7
第一次寻找审稿人：2021-11-15【未找到合适的审稿人】
第二次寻找审稿人：2021-12-20【这一次匹配到了合适的审稿人】
第一次有审稿意见（小修）：2022-1-25——修回时间2022-1-30
第二次有审稿意见（接收）：2022-2-1
总体感觉审稿速度还是不错的，文章之前投过其他杂志，虽然未接收，但是根据审稿意见进行了一些修改，对文章结构有明显改善，所以这次接收速度很快，希望对大家有所帮助！
2022年希望各位都能多发文章！！

181 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1189677, encodeId=13e611896e7f8, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：出凝血疾病 经验分享：大年初一，文章接收，很高兴第一次跟大家分享自己这次的投稿经历 投稿时间：2021-11-7 第一次寻找审稿人：2021-11-15【未找到合适的审稿人】 第二次寻找审稿人：2021-12-20【这一次匹配到了合适的审稿人】 第一次有审稿意见（小修）：2022-1-25——修回时间2022-1-30 第二次有审稿意见（接收）：2022-2-1 总体感觉审稿速度还是不错的，文章之前投过其他杂志，虽然未接收，但是根据审稿意见进行了一些修改，对文章结构有明显改善，所以这次接收速度很快，希望对大家有所帮助！ 2022年希望各位都能多发文章！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1f381668772, createdName=Su2016, createdTime=Wed Feb 02 11:28:12 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2248555, encodeId=3904224855562, content=投稿命中率:50.0 偏重的研究方向：出凝血疾病 经验分享：2024.12.18提交 2024.12.19 Reviewers are being invited and responses are being received 2024.12.28 Reviewers have been assigned and are completing reviews 一审结果未回持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5665325686, createdName=TJJQQ, createdTime=Fri Jan 17 23:18:06 CST 2025, time=2025-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101680, encodeId=809a210168062, content=偏重的研究方向：出凝血疾病 经验分享：2022.11.18提交 2022.11.19 Reviewers are being invited and responses are being received …持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e8349335, createdName=ms5000000019231764, createdTime=Sun Nov 20 23:13:04 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203613, encodeId=147922036133f, content=请问大家返修后Reviewers have been assigned and are completing reviews这个状态持续了多久呀等的实在太焦虑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b249042506, createdName=ms6000001836781261, createdTime=Thu May 09 10:09:09 CST 2024, time=2024-05-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109182, encodeId=ece72109182f2, content=2023.1.2接收，感觉审稿速度还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/7768d054ebc26df3dfa69122edc74935.jpg, createdBy=34ce1684797, createdName=1de4308em68(暂无匿称), createdTime=Fri Jan 06 22:14:24 CST 2023, time=2023-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1062859, encodeId=1e2f106285954, content=分享一下，proof之后2周就可以online了，需要自己检索 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=晔儿SK, createdTime=Fri Oct 22 09:36:18 CST 2021, time=2021-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211718, encodeId=4e692211e1825, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肺栓塞 经验分享：肺栓塞方向的文章 1.25投稿 3.25大修编辑的意见很专业细致，第一个编辑侧重点是需要说明文章的临床价值和背后的机制解释。有点忙隔了几个月才好好修，编辑没有催，好像是6个月还不返修需要向编辑说明。 6.6 返修 6.20 接受 人生第一篇独立的SCI！完美！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72015631190, createdName=ms4000001583451710, createdTime=Wed Jun 26 13:25:24 CST 2024, time=2024-06-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2178714, encodeId=706a21e8714ca, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这期刊编辑沟通顺畅，问题指出明确，真的很省心。投稿后编辑反馈及时，明白表达观点，省了好多麻烦，可以持续关注，希望明年影响因子能再提高一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfc06407071, createdName=ms5463223, createdTime=Tue Jan 02 09:34:01 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177818, encodeId=8f1721e7818d0, content=这期刊审稿效率还不错，一审一个月回复！而且编辑意见还很中肯，认真修改后2个月接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Thu Dec 28 16:36:16 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2118241, encodeId=12cb21182415b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：血栓 经验分享：交版面费时没有visa,mstercard,银联可以交么？<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>switch是什么卡, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99b78341791, createdName=ms3000001727854429, createdTime=Wed Mar 08 09:13:24 CST 2023, time=2023-03-08, status=1, ipAttribution=四川省)]

2025-01-17 TJJQQ

投稿命中率:50.0
偏重的研究方向：出凝血疾病
经验分享：2024.12.18提交
2024.12.19 Reviewers are being invited and responses are being received
2024.12.28 Reviewers have been assigned and are completing reviews
一审结果未回持续更新

0 6 举报

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1189677, encodeId=13e611896e7f8, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：出凝血疾病 经验分享：大年初一，文章接收，很高兴第一次跟大家分享自己这次的投稿经历 投稿时间：2021-11-7 第一次寻找审稿人：2021-11-15【未找到合适的审稿人】 第二次寻找审稿人：2021-12-20【这一次匹配到了合适的审稿人】 第一次有审稿意见（小修）：2022-1-25——修回时间2022-1-30 第二次有审稿意见（接收）：2022-2-1 总体感觉审稿速度还是不错的，文章之前投过其他杂志，虽然未接收，但是根据审稿意见进行了一些修改，对文章结构有明显改善，所以这次接收速度很快，希望对大家有所帮助！ 2022年希望各位都能多发文章！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1f381668772, createdName=Su2016, createdTime=Wed Feb 02 11:28:12 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2248555, encodeId=3904224855562, content=投稿命中率:50.0 偏重的研究方向：出凝血疾病 经验分享：2024.12.18提交 2024.12.19 Reviewers are being invited and responses are being received 2024.12.28 Reviewers have been assigned and are completing reviews 一审结果未回持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5665325686, createdName=TJJQQ, createdTime=Fri Jan 17 23:18:06 CST 2025, time=2025-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101680, encodeId=809a210168062, content=偏重的研究方向：出凝血疾病 经验分享：2022.11.18提交 2022.11.19 Reviewers are being invited and responses are being received …持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e8349335, createdName=ms5000000019231764, createdTime=Sun Nov 20 23:13:04 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203613, encodeId=147922036133f, content=请问大家返修后Reviewers have been assigned and are completing reviews这个状态持续了多久呀等的实在太焦虑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b249042506, createdName=ms6000001836781261, createdTime=Thu May 09 10:09:09 CST 2024, time=2024-05-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109182, encodeId=ece72109182f2, content=2023.1.2接收，感觉审稿速度还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/7768d054ebc26df3dfa69122edc74935.jpg, createdBy=34ce1684797, createdName=1de4308em68(暂无匿称), createdTime=Fri Jan 06 22:14:24 CST 2023, time=2023-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1062859, encodeId=1e2f106285954, content=分享一下，proof之后2周就可以online了，需要自己检索 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=晔儿SK, createdTime=Fri Oct 22 09:36:18 CST 2021, time=2021-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211718, encodeId=4e692211e1825, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肺栓塞 经验分享：肺栓塞方向的文章 1.25投稿 3.25大修编辑的意见很专业细致，第一个编辑侧重点是需要说明文章的临床价值和背后的机制解释。有点忙隔了几个月才好好修，编辑没有催，好像是6个月还不返修需要向编辑说明。 6.6 返修 6.20 接受 人生第一篇独立的SCI！完美！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72015631190, createdName=ms4000001583451710, createdTime=Wed Jun 26 13:25:24 CST 2024, time=2024-06-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2178714, encodeId=706a21e8714ca, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这期刊编辑沟通顺畅，问题指出明确，真的很省心。投稿后编辑反馈及时，明白表达观点，省了好多麻烦，可以持续关注，希望明年影响因子能再提高一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfc06407071, createdName=ms5463223, createdTime=Tue Jan 02 09:34:01 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177818, encodeId=8f1721e7818d0, content=这期刊审稿效率还不错，一审一个月回复！而且编辑意见还很中肯，认真修改后2个月接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Thu Dec 28 16:36:16 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2118241, encodeId=12cb21182415b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：血栓 经验分享：交版面费时没有visa,mstercard,银联可以交么？<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>switch是什么卡, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99b78341791, createdName=ms3000001727854429, createdTime=Wed Mar 08 09:13:24 CST 2023, time=2023-03-08, status=1, ipAttribution=四川省)]

2022-11-20 ms5000000019231764

偏重的研究方向：出凝血疾病
经验分享：2022.11.18提交 2022.11.19 Reviewers are being invited and responses are being received …持续更新

235 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1189677, encodeId=13e611896e7f8, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：出凝血疾病 经验分享：大年初一，文章接收，很高兴第一次跟大家分享自己这次的投稿经历 投稿时间：2021-11-7 第一次寻找审稿人：2021-11-15【未找到合适的审稿人】 第二次寻找审稿人：2021-12-20【这一次匹配到了合适的审稿人】 第一次有审稿意见（小修）：2022-1-25——修回时间2022-1-30 第二次有审稿意见（接收）：2022-2-1 总体感觉审稿速度还是不错的，文章之前投过其他杂志，虽然未接收，但是根据审稿意见进行了一些修改，对文章结构有明显改善，所以这次接收速度很快，希望对大家有所帮助！ 2022年希望各位都能多发文章！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1f381668772, createdName=Su2016, createdTime=Wed Feb 02 11:28:12 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2248555, encodeId=3904224855562, content=投稿命中率:50.0 偏重的研究方向：出凝血疾病 经验分享：2024.12.18提交 2024.12.19 Reviewers are being invited and responses are being received 2024.12.28 Reviewers have been assigned and are completing reviews 一审结果未回持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5665325686, createdName=TJJQQ, createdTime=Fri Jan 17 23:18:06 CST 2025, time=2025-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101680, encodeId=809a210168062, content=偏重的研究方向：出凝血疾病 经验分享：2022.11.18提交 2022.11.19 Reviewers are being invited and responses are being received …持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e8349335, createdName=ms5000000019231764, createdTime=Sun Nov 20 23:13:04 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203613, encodeId=147922036133f, content=请问大家返修后Reviewers have been assigned and are completing reviews这个状态持续了多久呀等的实在太焦虑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b249042506, createdName=ms6000001836781261, createdTime=Thu May 09 10:09:09 CST 2024, time=2024-05-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109182, encodeId=ece72109182f2, content=2023.1.2接收，感觉审稿速度还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/7768d054ebc26df3dfa69122edc74935.jpg, createdBy=34ce1684797, createdName=1de4308em68(暂无匿称), createdTime=Fri Jan 06 22:14:24 CST 2023, time=2023-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1062859, encodeId=1e2f106285954, content=分享一下，proof之后2周就可以online了，需要自己检索 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=晔儿SK, createdTime=Fri Oct 22 09:36:18 CST 2021, time=2021-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211718, encodeId=4e692211e1825, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肺栓塞 经验分享：肺栓塞方向的文章 1.25投稿 3.25大修编辑的意见很专业细致，第一个编辑侧重点是需要说明文章的临床价值和背后的机制解释。有点忙隔了几个月才好好修，编辑没有催，好像是6个月还不返修需要向编辑说明。 6.6 返修 6.20 接受 人生第一篇独立的SCI！完美！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72015631190, createdName=ms4000001583451710, createdTime=Wed Jun 26 13:25:24 CST 2024, time=2024-06-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2178714, encodeId=706a21e8714ca, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这期刊编辑沟通顺畅，问题指出明确，真的很省心。投稿后编辑反馈及时，明白表达观点，省了好多麻烦，可以持续关注，希望明年影响因子能再提高一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfc06407071, createdName=ms5463223, createdTime=Tue Jan 02 09:34:01 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177818, encodeId=8f1721e7818d0, content=这期刊审稿效率还不错，一审一个月回复！而且编辑意见还很中肯，认真修改后2个月接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Thu Dec 28 16:36:16 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2118241, encodeId=12cb21182415b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：血栓 经验分享：交版面费时没有visa,mstercard,银联可以交么？<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>switch是什么卡, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99b78341791, createdName=ms3000001727854429, createdTime=Wed Mar 08 09:13:24 CST 2023, time=2023-03-08, status=1, ipAttribution=四川省)]

2024-05-09 ms6000001836781261 来自湖北省

请问大家返修后Reviewers have been assigned and are completing reviews这个状态持续了多久呀等的实在太焦虑了

164 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1189677, encodeId=13e611896e7f8, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：出凝血疾病 经验分享：大年初一，文章接收，很高兴第一次跟大家分享自己这次的投稿经历 投稿时间：2021-11-7 第一次寻找审稿人：2021-11-15【未找到合适的审稿人】 第二次寻找审稿人：2021-12-20【这一次匹配到了合适的审稿人】 第一次有审稿意见（小修）：2022-1-25——修回时间2022-1-30 第二次有审稿意见（接收）：2022-2-1 总体感觉审稿速度还是不错的，文章之前投过其他杂志，虽然未接收，但是根据审稿意见进行了一些修改，对文章结构有明显改善，所以这次接收速度很快，希望对大家有所帮助！ 2022年希望各位都能多发文章！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1f381668772, createdName=Su2016, createdTime=Wed Feb 02 11:28:12 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2248555, encodeId=3904224855562, content=投稿命中率:50.0 偏重的研究方向：出凝血疾病 经验分享：2024.12.18提交 2024.12.19 Reviewers are being invited and responses are being received 2024.12.28 Reviewers have been assigned and are completing reviews 一审结果未回持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5665325686, createdName=TJJQQ, createdTime=Fri Jan 17 23:18:06 CST 2025, time=2025-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101680, encodeId=809a210168062, content=偏重的研究方向：出凝血疾病 经验分享：2022.11.18提交 2022.11.19 Reviewers are being invited and responses are being received …持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e8349335, createdName=ms5000000019231764, createdTime=Sun Nov 20 23:13:04 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203613, encodeId=147922036133f, content=请问大家返修后Reviewers have been assigned and are completing reviews这个状态持续了多久呀等的实在太焦虑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b249042506, createdName=ms6000001836781261, createdTime=Thu May 09 10:09:09 CST 2024, time=2024-05-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109182, encodeId=ece72109182f2, content=2023.1.2接收，感觉审稿速度还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/7768d054ebc26df3dfa69122edc74935.jpg, createdBy=34ce1684797, createdName=1de4308em68(暂无匿称), createdTime=Fri Jan 06 22:14:24 CST 2023, time=2023-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1062859, encodeId=1e2f106285954, content=分享一下，proof之后2周就可以online了，需要自己检索 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=晔儿SK, createdTime=Fri Oct 22 09:36:18 CST 2021, time=2021-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211718, encodeId=4e692211e1825, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肺栓塞 经验分享：肺栓塞方向的文章 1.25投稿 3.25大修编辑的意见很专业细致，第一个编辑侧重点是需要说明文章的临床价值和背后的机制解释。有点忙隔了几个月才好好修，编辑没有催，好像是6个月还不返修需要向编辑说明。 6.6 返修 6.20 接受 人生第一篇独立的SCI！完美！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72015631190, createdName=ms4000001583451710, createdTime=Wed Jun 26 13:25:24 CST 2024, time=2024-06-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2178714, encodeId=706a21e8714ca, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这期刊编辑沟通顺畅，问题指出明确，真的很省心。投稿后编辑反馈及时，明白表达观点，省了好多麻烦，可以持续关注，希望明年影响因子能再提高一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfc06407071, createdName=ms5463223, createdTime=Tue Jan 02 09:34:01 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177818, encodeId=8f1721e7818d0, content=这期刊审稿效率还不错，一审一个月回复！而且编辑意见还很中肯，认真修改后2个月接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Thu Dec 28 16:36:16 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2118241, encodeId=12cb21182415b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：血栓 经验分享：交版面费时没有visa,mstercard,银联可以交么？<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>switch是什么卡, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99b78341791, createdName=ms3000001727854429, createdTime=Wed Mar 08 09:13:24 CST 2023, time=2023-03-08, status=1, ipAttribution=四川省)]

2023-01-06 1de4308em68(暂无匿称) 来自浙江省

2023.1.2接收，感觉审稿速度还可以。

181 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1189677, encodeId=13e611896e7f8, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：出凝血疾病 经验分享：大年初一，文章接收，很高兴第一次跟大家分享自己这次的投稿经历 投稿时间：2021-11-7 第一次寻找审稿人：2021-11-15【未找到合适的审稿人】 第二次寻找审稿人：2021-12-20【这一次匹配到了合适的审稿人】 第一次有审稿意见（小修）：2022-1-25——修回时间2022-1-30 第二次有审稿意见（接收）：2022-2-1 总体感觉审稿速度还是不错的，文章之前投过其他杂志，虽然未接收，但是根据审稿意见进行了一些修改，对文章结构有明显改善，所以这次接收速度很快，希望对大家有所帮助！ 2022年希望各位都能多发文章！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1f381668772, createdName=Su2016, createdTime=Wed Feb 02 11:28:12 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2248555, encodeId=3904224855562, content=投稿命中率:50.0 偏重的研究方向：出凝血疾病 经验分享：2024.12.18提交 2024.12.19 Reviewers are being invited and responses are being received 2024.12.28 Reviewers have been assigned and are completing reviews 一审结果未回持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5665325686, createdName=TJJQQ, createdTime=Fri Jan 17 23:18:06 CST 2025, time=2025-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101680, encodeId=809a210168062, content=偏重的研究方向：出凝血疾病 经验分享：2022.11.18提交 2022.11.19 Reviewers are being invited and responses are being received …持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e8349335, createdName=ms5000000019231764, createdTime=Sun Nov 20 23:13:04 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203613, encodeId=147922036133f, content=请问大家返修后Reviewers have been assigned and are completing reviews这个状态持续了多久呀等的实在太焦虑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b249042506, createdName=ms6000001836781261, createdTime=Thu May 09 10:09:09 CST 2024, time=2024-05-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109182, encodeId=ece72109182f2, content=2023.1.2接收，感觉审稿速度还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/7768d054ebc26df3dfa69122edc74935.jpg, createdBy=34ce1684797, createdName=1de4308em68(暂无匿称), createdTime=Fri Jan 06 22:14:24 CST 2023, time=2023-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1062859, encodeId=1e2f106285954, content=分享一下，proof之后2周就可以online了，需要自己检索 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=晔儿SK, createdTime=Fri Oct 22 09:36:18 CST 2021, time=2021-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211718, encodeId=4e692211e1825, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肺栓塞 经验分享：肺栓塞方向的文章 1.25投稿 3.25大修编辑的意见很专业细致，第一个编辑侧重点是需要说明文章的临床价值和背后的机制解释。有点忙隔了几个月才好好修，编辑没有催，好像是6个月还不返修需要向编辑说明。 6.6 返修 6.20 接受 人生第一篇独立的SCI！完美！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72015631190, createdName=ms4000001583451710, createdTime=Wed Jun 26 13:25:24 CST 2024, time=2024-06-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2178714, encodeId=706a21e8714ca, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这期刊编辑沟通顺畅，问题指出明确，真的很省心。投稿后编辑反馈及时，明白表达观点，省了好多麻烦，可以持续关注，希望明年影响因子能再提高一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfc06407071, createdName=ms5463223, createdTime=Tue Jan 02 09:34:01 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177818, encodeId=8f1721e7818d0, content=这期刊审稿效率还不错，一审一个月回复！而且编辑意见还很中肯，认真修改后2个月接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Thu Dec 28 16:36:16 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2118241, encodeId=12cb21182415b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：血栓 经验分享：交版面费时没有visa,mstercard,银联可以交么？<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>switch是什么卡, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99b78341791, createdName=ms3000001727854429, createdTime=Wed Mar 08 09:13:24 CST 2023, time=2023-03-08, status=1, ipAttribution=四川省)]

2021-10-22 晔儿SK

分享一下，proof之后2周就可以online了，需要自己检索

186 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1189677, encodeId=13e611896e7f8, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：出凝血疾病 经验分享：大年初一，文章接收，很高兴第一次跟大家分享自己这次的投稿经历 投稿时间：2021-11-7 第一次寻找审稿人：2021-11-15【未找到合适的审稿人】 第二次寻找审稿人：2021-12-20【这一次匹配到了合适的审稿人】 第一次有审稿意见（小修）：2022-1-25——修回时间2022-1-30 第二次有审稿意见（接收）：2022-2-1 总体感觉审稿速度还是不错的，文章之前投过其他杂志，虽然未接收，但是根据审稿意见进行了一些修改，对文章结构有明显改善，所以这次接收速度很快，希望对大家有所帮助！ 2022年希望各位都能多发文章！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1f381668772, createdName=Su2016, createdTime=Wed Feb 02 11:28:12 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2248555, encodeId=3904224855562, content=投稿命中率:50.0 偏重的研究方向：出凝血疾病 经验分享：2024.12.18提交 2024.12.19 Reviewers are being invited and responses are being received 2024.12.28 Reviewers have been assigned and are completing reviews 一审结果未回持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5665325686, createdName=TJJQQ, createdTime=Fri Jan 17 23:18:06 CST 2025, time=2025-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101680, encodeId=809a210168062, content=偏重的研究方向：出凝血疾病 经验分享：2022.11.18提交 2022.11.19 Reviewers are being invited and responses are being received …持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e8349335, createdName=ms5000000019231764, createdTime=Sun Nov 20 23:13:04 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203613, encodeId=147922036133f, content=请问大家返修后Reviewers have been assigned and are completing reviews这个状态持续了多久呀等的实在太焦虑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b249042506, createdName=ms6000001836781261, createdTime=Thu May 09 10:09:09 CST 2024, time=2024-05-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109182, encodeId=ece72109182f2, content=2023.1.2接收，感觉审稿速度还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/7768d054ebc26df3dfa69122edc74935.jpg, createdBy=34ce1684797, createdName=1de4308em68(暂无匿称), createdTime=Fri Jan 06 22:14:24 CST 2023, time=2023-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1062859, encodeId=1e2f106285954, content=分享一下，proof之后2周就可以online了，需要自己检索 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=晔儿SK, createdTime=Fri Oct 22 09:36:18 CST 2021, time=2021-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211718, encodeId=4e692211e1825, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肺栓塞 经验分享：肺栓塞方向的文章 1.25投稿 3.25大修编辑的意见很专业细致，第一个编辑侧重点是需要说明文章的临床价值和背后的机制解释。有点忙隔了几个月才好好修，编辑没有催，好像是6个月还不返修需要向编辑说明。 6.6 返修 6.20 接受 人生第一篇独立的SCI！完美！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72015631190, createdName=ms4000001583451710, createdTime=Wed Jun 26 13:25:24 CST 2024, time=2024-06-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2178714, encodeId=706a21e8714ca, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这期刊编辑沟通顺畅，问题指出明确，真的很省心。投稿后编辑反馈及时，明白表达观点，省了好多麻烦，可以持续关注，希望明年影响因子能再提高一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfc06407071, createdName=ms5463223, createdTime=Tue Jan 02 09:34:01 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177818, encodeId=8f1721e7818d0, content=这期刊审稿效率还不错，一审一个月回复！而且编辑意见还很中肯，认真修改后2个月接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Thu Dec 28 16:36:16 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2118241, encodeId=12cb21182415b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：血栓 经验分享：交版面费时没有visa,mstercard,银联可以交么？<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>switch是什么卡, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99b78341791, createdName=ms3000001727854429, createdTime=Wed Mar 08 09:13:24 CST 2023, time=2023-03-08, status=1, ipAttribution=四川省)]

2024-06-26 ms4000001583451710 来自北京

审稿速度:2.0 | 投稿命中率:95.0
偏重的研究方向：肺栓塞
经验分享：肺栓塞方向的文章
1.25投稿
3.25大修编辑的意见很专业细致，第一个编辑侧重点是需要说明文章的临床价值和背后的机制解释。有点忙隔了几个月才好好修，编辑没有催，好像是6个月还不返修需要向编辑说明。
6.6 返修
6.20 接受
人生第一篇独立的SCI！完美！

142 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1189677, encodeId=13e611896e7f8, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：出凝血疾病 经验分享：大年初一，文章接收，很高兴第一次跟大家分享自己这次的投稿经历 投稿时间：2021-11-7 第一次寻找审稿人：2021-11-15【未找到合适的审稿人】 第二次寻找审稿人：2021-12-20【这一次匹配到了合适的审稿人】 第一次有审稿意见（小修）：2022-1-25——修回时间2022-1-30 第二次有审稿意见（接收）：2022-2-1 总体感觉审稿速度还是不错的，文章之前投过其他杂志，虽然未接收，但是根据审稿意见进行了一些修改，对文章结构有明显改善，所以这次接收速度很快，希望对大家有所帮助！ 2022年希望各位都能多发文章！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1f381668772, createdName=Su2016, createdTime=Wed Feb 02 11:28:12 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2248555, encodeId=3904224855562, content=投稿命中率:50.0 偏重的研究方向：出凝血疾病 经验分享：2024.12.18提交 2024.12.19 Reviewers are being invited and responses are being received 2024.12.28 Reviewers have been assigned and are completing reviews 一审结果未回持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5665325686, createdName=TJJQQ, createdTime=Fri Jan 17 23:18:06 CST 2025, time=2025-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101680, encodeId=809a210168062, content=偏重的研究方向：出凝血疾病 经验分享：2022.11.18提交 2022.11.19 Reviewers are being invited and responses are being received …持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e8349335, createdName=ms5000000019231764, createdTime=Sun Nov 20 23:13:04 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203613, encodeId=147922036133f, content=请问大家返修后Reviewers have been assigned and are completing reviews这个状态持续了多久呀等的实在太焦虑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b249042506, createdName=ms6000001836781261, createdTime=Thu May 09 10:09:09 CST 2024, time=2024-05-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109182, encodeId=ece72109182f2, content=2023.1.2接收，感觉审稿速度还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/7768d054ebc26df3dfa69122edc74935.jpg, createdBy=34ce1684797, createdName=1de4308em68(暂无匿称), createdTime=Fri Jan 06 22:14:24 CST 2023, time=2023-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1062859, encodeId=1e2f106285954, content=分享一下，proof之后2周就可以online了，需要自己检索 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=晔儿SK, createdTime=Fri Oct 22 09:36:18 CST 2021, time=2021-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211718, encodeId=4e692211e1825, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肺栓塞 经验分享：肺栓塞方向的文章 1.25投稿 3.25大修编辑的意见很专业细致，第一个编辑侧重点是需要说明文章的临床价值和背后的机制解释。有点忙隔了几个月才好好修，编辑没有催，好像是6个月还不返修需要向编辑说明。 6.6 返修 6.20 接受 人生第一篇独立的SCI！完美！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72015631190, createdName=ms4000001583451710, createdTime=Wed Jun 26 13:25:24 CST 2024, time=2024-06-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2178714, encodeId=706a21e8714ca, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这期刊编辑沟通顺畅，问题指出明确，真的很省心。投稿后编辑反馈及时，明白表达观点，省了好多麻烦，可以持续关注，希望明年影响因子能再提高一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfc06407071, createdName=ms5463223, createdTime=Tue Jan 02 09:34:01 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177818, encodeId=8f1721e7818d0, content=这期刊审稿效率还不错，一审一个月回复！而且编辑意见还很中肯，认真修改后2个月接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Thu Dec 28 16:36:16 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2118241, encodeId=12cb21182415b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：血栓 经验分享：交版面费时没有visa,mstercard,银联可以交么？<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>switch是什么卡, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99b78341791, createdName=ms3000001727854429, createdTime=Wed Mar 08 09:13:24 CST 2023, time=2023-03-08, status=1, ipAttribution=四川省)]

2024-01-02 ms5463223 来自上海

审稿速度:3.0 | 投稿命中率:50.0
经验分享：这期刊编辑沟通顺畅，问题指出明确，真的很省心。投稿后编辑反馈及时，明白表达观点，省了好多麻烦，可以持续关注，希望明年影响因子能再提高一些

143 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=1189677, encodeId=13e611896e7f8, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：出凝血疾病 经验分享：大年初一，文章接收，很高兴第一次跟大家分享自己这次的投稿经历 投稿时间：2021-11-7 第一次寻找审稿人：2021-11-15【未找到合适的审稿人】 第二次寻找审稿人：2021-12-20【这一次匹配到了合适的审稿人】 第一次有审稿意见（小修）：2022-1-25——修回时间2022-1-30 第二次有审稿意见（接收）：2022-2-1 总体感觉审稿速度还是不错的，文章之前投过其他杂志，虽然未接收，但是根据审稿意见进行了一些修改，对文章结构有明显改善，所以这次接收速度很快，希望对大家有所帮助！ 2022年希望各位都能多发文章！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1f381668772, createdName=Su2016, createdTime=Wed Feb 02 11:28:12 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2248555, encodeId=3904224855562, content=投稿命中率:50.0 偏重的研究方向：出凝血疾病 经验分享：2024.12.18提交 2024.12.19 Reviewers are being invited and responses are being received 2024.12.28 Reviewers have been assigned and are completing reviews 一审结果未回持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5665325686, createdName=TJJQQ, createdTime=Fri Jan 17 23:18:06 CST 2025, time=2025-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101680, encodeId=809a210168062, content=偏重的研究方向：出凝血疾病 经验分享：2022.11.18提交 2022.11.19 Reviewers are being invited and responses are being received …持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e8349335, createdName=ms5000000019231764, createdTime=Sun Nov 20 23:13:04 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203613, encodeId=147922036133f, content=请问大家返修后Reviewers have been assigned and are completing reviews这个状态持续了多久呀等的实在太焦虑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b249042506, createdName=ms6000001836781261, createdTime=Thu May 09 10:09:09 CST 2024, time=2024-05-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109182, encodeId=ece72109182f2, content=2023.1.2接收，感觉审稿速度还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/7768d054ebc26df3dfa69122edc74935.jpg, createdBy=34ce1684797, createdName=1de4308em68(暂无匿称), createdTime=Fri Jan 06 22:14:24 CST 2023, time=2023-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1062859, encodeId=1e2f106285954, content=分享一下，proof之后2周就可以online了，需要自己检索 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=晔儿SK, createdTime=Fri Oct 22 09:36:18 CST 2021, time=2021-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211718, encodeId=4e692211e1825, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肺栓塞 经验分享：肺栓塞方向的文章 1.25投稿 3.25大修编辑的意见很专业细致，第一个编辑侧重点是需要说明文章的临床价值和背后的机制解释。有点忙隔了几个月才好好修，编辑没有催，好像是6个月还不返修需要向编辑说明。 6.6 返修 6.20 接受 人生第一篇独立的SCI！完美！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72015631190, createdName=ms4000001583451710, createdTime=Wed Jun 26 13:25:24 CST 2024, time=2024-06-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2178714, encodeId=706a21e8714ca, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这期刊编辑沟通顺畅，问题指出明确，真的很省心。投稿后编辑反馈及时，明白表达观点，省了好多麻烦，可以持续关注，希望明年影响因子能再提高一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfc06407071, createdName=ms5463223, createdTime=Tue Jan 02 09:34:01 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177818, encodeId=8f1721e7818d0, content=这期刊审稿效率还不错，一审一个月回复！而且编辑意见还很中肯，认真修改后2个月接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Thu Dec 28 16:36:16 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2118241, encodeId=12cb21182415b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：血栓 经验分享：交版面费时没有visa,mstercard,银联可以交么？<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>switch是什么卡, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99b78341791, createdName=ms3000001727854429, createdTime=Wed Mar 08 09:13:24 CST 2023, time=2023-03-08, status=1, ipAttribution=四川省)]

2023-12-28 Gym璨烨来自上海

这期刊审稿效率还不错，一审一个月回复！而且编辑意见还很中肯，认真修改后2个月接收。

154 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=1189677, encodeId=13e611896e7f8, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：出凝血疾病 经验分享：大年初一，文章接收，很高兴第一次跟大家分享自己这次的投稿经历 投稿时间：2021-11-7 第一次寻找审稿人：2021-11-15【未找到合适的审稿人】 第二次寻找审稿人：2021-12-20【这一次匹配到了合适的审稿人】 第一次有审稿意见（小修）：2022-1-25——修回时间2022-1-30 第二次有审稿意见（接收）：2022-2-1 总体感觉审稿速度还是不错的，文章之前投过其他杂志，虽然未接收，但是根据审稿意见进行了一些修改，对文章结构有明显改善，所以这次接收速度很快，希望对大家有所帮助！ 2022年希望各位都能多发文章！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1f381668772, createdName=Su2016, createdTime=Wed Feb 02 11:28:12 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2248555, encodeId=3904224855562, content=投稿命中率:50.0 偏重的研究方向：出凝血疾病 经验分享：2024.12.18提交 2024.12.19 Reviewers are being invited and responses are being received 2024.12.28 Reviewers have been assigned and are completing reviews 一审结果未回持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5665325686, createdName=TJJQQ, createdTime=Fri Jan 17 23:18:06 CST 2025, time=2025-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101680, encodeId=809a210168062, content=偏重的研究方向：出凝血疾病 经验分享：2022.11.18提交 2022.11.19 Reviewers are being invited and responses are being received …持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e8349335, createdName=ms5000000019231764, createdTime=Sun Nov 20 23:13:04 CST 2022, time=2022-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203613, encodeId=147922036133f, content=请问大家返修后Reviewers have been assigned and are completing reviews这个状态持续了多久呀等的实在太焦虑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b249042506, createdName=ms6000001836781261, createdTime=Thu May 09 10:09:09 CST 2024, time=2024-05-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109182, encodeId=ece72109182f2, content=2023.1.2接收，感觉审稿速度还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/7768d054ebc26df3dfa69122edc74935.jpg, createdBy=34ce1684797, createdName=1de4308em68(暂无匿称), createdTime=Fri Jan 06 22:14:24 CST 2023, time=2023-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1062859, encodeId=1e2f106285954, content=分享一下，proof之后2周就可以online了，需要自己检索 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=晔儿SK, createdTime=Fri Oct 22 09:36:18 CST 2021, time=2021-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211718, encodeId=4e692211e1825, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肺栓塞 经验分享：肺栓塞方向的文章 1.25投稿 3.25大修编辑的意见很专业细致，第一个编辑侧重点是需要说明文章的临床价值和背后的机制解释。有点忙隔了几个月才好好修，编辑没有催，好像是6个月还不返修需要向编辑说明。 6.6 返修 6.20 接受 人生第一篇独立的SCI！完美！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72015631190, createdName=ms4000001583451710, createdTime=Wed Jun 26 13:25:24 CST 2024, time=2024-06-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2178714, encodeId=706a21e8714ca, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这期刊编辑沟通顺畅，问题指出明确，真的很省心。投稿后编辑反馈及时，明白表达观点，省了好多麻烦，可以持续关注，希望明年影响因子能再提高一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfc06407071, createdName=ms5463223, createdTime=Tue Jan 02 09:34:01 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177818, encodeId=8f1721e7818d0, content=这期刊审稿效率还不错，一审一个月回复！而且编辑意见还很中肯，认真修改后2个月接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Thu Dec 28 16:36:16 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2118241, encodeId=12cb21182415b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：血栓 经验分享：交版面费时没有visa,mstercard,银联可以交么？<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>switch是什么卡, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99b78341791, createdName=ms3000001727854429, createdTime=Wed Mar 08 09:13:24 CST 2023, time=2023-03-08, status=1, ipAttribution=四川省)]

2023-03-08 ms3000001727854429 来自四川省

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：血栓
经验分享：交版面费时没有visa,mstercard,银联可以交么？#期刊论坛#switch是什么卡

170 0 举报

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务